# Nutraceutical Supplement in the Management of Hypertension

> **NCT02663479** · PHASE1,PHASE2 · COMPLETED · sponsor: **Thorne HealthTech, Inc** · enrollment: 40 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DIETARY_SUPPLEMENT:** Cardiopressin
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02663479
- **Lead sponsor:** Thorne HealthTech, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2017-08
- **Final completion:** 2017-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02663479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02663479, "Nutraceutical Supplement in the Management of Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02663479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*